Strain-Dependent Variation inMycobacterium bovisBCG-Induced Human T-Cell Activation and Gamma Interferon Production In Vitro
Ana M. Aguirre-Blanco, Pauline T. Lukey, Jacqueline M. Cliff, Hazel M. Dockrell
Abstract
Ana M. Aguirre-Blanco, Pauline T. Lukey, Jacqueline M. Cliff, Hazel M. Dockrell
Abstract
Three commonly used Mycobacterium bovis BCG vaccine strains elicited different magnitudes of T-cell activation and gamma interferon production in vitro in healthy BCG-vaccinated individuals. Glaxo 1077 exhibited the greatest stimulatory capacity, followed by Pasteur 1173 and then Danish 1331. These differences may affect in vitro stimulation and vaccination-induced immunogenicity.
OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Three commonly used Mycobacterium bovis BCG vaccine strains elicited different magnitudes of T-cell activation and gamma interferon production in vitro in healthy BCG-vaccinated individuals. Glaxo 1077 exhibited the greatest stimulatory capacity, followed by Pasteur 1173 and then Danish 1331. These differences may affect in vitro stimulation and vaccination-induced immunogenicity.
Key concepts: Mycobacterium bovis, Biology, Immunogenicity, In vitro, Interferon gamma, BCG vaccine, Vaccination, Microbiology